Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Top Cited Papers
Open Access
- 10 January 2006
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 20 (3) , 419-425
- https://doi.org/10.1096/fj.03-1449com
Abstract
To date there is no accepted clinical diagnostic test for Parkinson's disease (PD) based on biochemical analysis of blood or cerebrospinal fluid (CSF). α-Synuclein (α-syn) protein has been linked to ...Keywords
Funding Information
- Michael J. Fox Foundation for Parkinson's Research
- Alzheimer's Research Trust
This publication has 34 references indexed in Scilit:
- α-synuclein locus duplication as a cause of familial Parkinson's diseasePublished by Elsevier ,2004
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's diseaseFEBS Letters, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Identification of two distinct synucleins from human brainFEBS Letters, 1994